[Pharmacokinetics of amphotericin B and its derivatives]. 1991

I F Vetkina

UI MeSH Term Description Entries
D009181 Mycoses Diseases caused by FUNGI. Fungus Diseases,Fungal Diseases,Fungal Infections,Fungus Infections,Disease, Fungal,Disease, Fungus,Diseases, Fungal,Diseases, Fungus,Fungal Disease,Fungal Infection,Fungus Disease,Fungus Infection,Infection, Fungal,Infection, Fungus,Infections, Fungal,Infections, Fungus
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000666 Amphotericin B Macrolide antifungal antibiotic produced by Streptomyces nodosus obtained from soil of the Orinoco river region of Venezuela. Amphocil,Amphotericin,Amphotericin B Cholesterol Dispersion,Amphotericin B Colloidal Dispersion,Fungizone
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics

Related Publications

I F Vetkina
June 2009, Current drug metabolism,
I F Vetkina
October 2006, Antimicrobial agents and chemotherapy,
I F Vetkina
September 1979, Postgraduate medical journal,
I F Vetkina
February 1978, Antimicrobial agents and chemotherapy,
I F Vetkina
November 1989, Antimicrobial agents and chemotherapy,
I F Vetkina
June 1969, The American review of respiratory disease,
I F Vetkina
January 1992, Respiration; international review of thoracic diseases,
I F Vetkina
April 1987, The Journal of infectious diseases,
I F Vetkina
January 1990, Antimicrobial agents and chemotherapy,
Copied contents to your clipboard!